FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders

Cancers and neurological disorders are two major types of diseases. We previously developed a new concept termed “Aberrant Cell Cycle Diseases” (ACCD), revealing that these two diseases share a common mechanism of aberrant cell cycle re-entry. The aberrant cell cycle re-entry is manifested as kinase...

Descripción completa

Detalles Bibliográficos
Autores principales: Lui, Austin, Vanleuven, Jordan, Perekopskiy, David, Liu, Dewey, Xu, Desiree, Alzayat, Omar, Elgokhy, Taiseer, Do, Timothy, Gann, Meghan, Martin, Ryan, Liu, Da-Zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784968/
https://www.ncbi.nlm.nih.gov/pubmed/36558997
http://dx.doi.org/10.3390/ph15121546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784968/
https://www.ncbi.nlm.nih.gov/pubmed/36558997
http://dx.doi.org/10.3390/ph15121546

Ejemplares similares